Wednesday, November 18, 2020 @ 3-4:30pm ET (2CT/1MT/12PT)
Adolescence is a unique and active period of development. Differential diagnostic understanding and treatment is complicated, specialized, and vital. Often, protective change and treatment progress can be stalled by unrecognized areas of risk and need. As many as 40% of adolescents with identified mental health needs have co-occurring substance use issues. Identified substance use needs predict co-occurring mental health disorders over 70% of the time. Treatment retention and progress, safety factors, and beneficial change are all improved with integrated applications. This integrative approach can be initially daunting for clinicians. Adolescents with CODs are already in our care – and integrating care provides the better opportunity for healthy changes for youth and families.
Describe current research regarding youth with co-occurring disorders – including prevalence(s) - and list factors that differentiate youth from adults.
Describe how physical, social, and personality development factors during adolescents can be dramatically impacted by substance use/abuse, trauma/victimization and mental health disorders.
Describe screening and assessment from an integrated perspective.
Wednesday, October 28, 2020 @ 3-4:00pm ET (2CT/1MT/12PT)
Hailed as safe, natural and a potential cure-all by the public, both medical and recreational cannabis is quickly becoming legal and mainstream across the country. While it has the potential to help fill state coffers, there are many unintended consequences that will mean big challenges for addiction specialists. This webinar will provide an overview of issues related to cannabis legalization, including: federal limitations on research, variations in potency and routes of administration, adverse impacts on vulnerable populations, current evidence for treating opioid addiction and public safety risks such as driving under the influence. The session will conclude with tips and resources for addressing this issue with patients and their families.
Recognize current trends in cannabis policies and regulations.
Identify emerging cannabis products.
Describe unintended and evolving consequences of cannabis legalization.
A 2ª Edição da Conferência Global sobre Medicina do Vício, Saúde Comportamental e Psiquiatria" será realizada de 22 a 24 de outubro de 2020 em Orlando, EUA.
O tema do evento é "Unificar as novas descobertas e abordagens avançadas para o vício e psiquiatria."
O evento tem como objetivo oferecer uma plataforma excepcional que abrange todo o espectro de pesquisa e inovações em dependência e áreas relacionadas e compartilhar as proficiências interculturais de vários avanços neste campo, proporcionando a exploração aprofundada.
La 2a Edición de la Conferencia Mundial sobre Medicina de las Adicciones, Salud del Comportamiento y Psiquiatría" se llevará a cabo del 22 al 24 de octubre de 2020 en Orlando, EE. UU.
El tema del evento es"Unificar los nuevos descubrimientos y enfoques avanzados hacia la Adicción y la Psiquiatría".
El evento tiene como objetivo ofrecer una plataforma excepcional que cubra todo el espectro de investigación e innovaciones en las adicciones y áreas relacionadas y compartir las competencias interculturales de diversos avances en este campo proporcionando la exploración en profundidad.
The 2nd Edition of Global Conference on Addiction Medicine, Behavioural health and Psychiatry” will be held on October 22-24, 2020 at Orlando, USA.
The theme of the event is “Unifying the new discoveries and advanced approaches towards Addiction and Psychiatry.”
The event aims to deliver an outstanding platform which covers the entire spectrum of research & innovations in addiction and related areas and share the cross-cultural proficiencies of various advancements in this field providing the in-depth exploration.
Se invita a los miembros y no miembros de la NAADAC a que presenten una propuesta de presentación para una sesión de ruptura de 1,5 horas relativa a la información actual y pertinente sobre uno de estos nueve temas:
Gestión de Prácticas, Administración/Operación y Tecnología
Psicofarmacología, Tratamiento Asistido con Medicamentos o Farmacoterapia
Adicciones al proceso
Soporte de recuperación (clínico)
Recuperación del par (no clínica)
Fecha límite de presentación: Miércoles, 22 de enero de 2020
Wednesday, September 2, 2020 @ 3-4:00pm ET (2CT/1MT/12PT)
While natural and human-made disasters continue to plague humankind, the impact of disasters on people in recovery is a largely unexplored territory. In consideration of the fact that disruption of the person's life can put them at risk for relapse, the astute therapist knows that these unexpected events can cause significant distress to the client and possibly have a negative impact on their recovery. In this session, we review the nature of disasters and the role of disaster recovery planning in helping the client to maintain recovery goals during disaster situations.
Describe natural and human-made disasters and how they can disrupt the lives of people in recovery.
Discuss the psychological implications of disasters and the potential negative consequences that disasters can have on personal recovery goals.
The critical role of clinical supervision in both staff development and retention are well-documented. The disconnect between the need for clinical supervision and the consistent provision thereof in the field, however, is often attributable to common barriers experienced among service providers. This session will explore common challenges and points of resistance to the provision of consistent, effective supervision, principles for improving the delivery of needed supervision, and offer practical examples of the application of these principles in the field.
Identify two barriers to consistent, effective clinical supervision.
Articulate principles and suggestions designed to enhance the delivery of clinical supervision in diverse settings.
Self -assess the level of training needs and strategies needed to move forward with EBS implementation.
Wednesday, August 5, 2020 @ 3-4:00pm ET (2CT/1MT/12PT)